Long Qt Syndrome

Sudden cardiac death among athletes, both recreational and master level, remains a public health issue, disparately affecting players of certain sports and athlete demographics, researchers reported.

Pre-participation screening, particularly whether an ECG should be included as part of a pre-participation exam for young athletes, is one of the most widely debated topics in sports cardiology.

In patients with long QT syndrome, vigorous exercise did not appear to increase CV event risk vs. nonvigorous exercise regardless of age, sex or genotype, according to new data from the LIVE-LQTS study presented at Heart Rhythm 2024.

No athlete with a positive test for genetic heart disease but a negligible clinical phenotype had a genetic heart disease-associated death or cardiac event in more than 1,500 person-years of follow-up, researchers reported.

PHILADELPHIA — In people with congenital long QT syndrome, vigorous exercise did not raise risk for death or ventricular arrhythmias compared with nonvigorous exercise, according to the results of the LIVE-LQTS study.

Women with long QT syndrome taking progestin-only oral contraceptives were at elevated risk for cardiac events, according to a study presented at Heart Rhythm 2021.

In a cohort of athletes with long QT syndrome or other genetic heart diseases who were approved to return to play, there were no sports-related deaths over 20 years, researchers reported at Heart Rhythm 2021.

In May, the Heart Rhythm Society Annual Scientific Sessions were held virtually for the first time. Attendees were able to access sessions via the HRS Learning Portal at heartrhythm365.org.

Researchers have developed an online calculator to assess 5-year risk for life-threatening arrhythmic events in patients with long QT syndrome.

Understanding COVID-19 and SARS-CoV-2 is imperative for the cardiology community, and beyond. To that end, Cardiology Today and Healio convened a panel of experts to discuss the CV implications of COVID-19 and the virus that causes it.